| 1 |
|
A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: the ADMIRE (AmP579 delivery for myo/
|
Kopecky, S. L
|
C. V. Mosby Co
|
2003
|
|
|
|
| 2 |
|
A randomized, placebo-controlled trial of early eptifibatide for non-ST-segment elevation acute coronary syndromes/
|
Roe, M. T
|
C. V. Mosby Co
|
2003
|
|
|
|
| 3 |
|
Racial disparity in long-term mortality rate after hospitalization for myocardial infarction: the Atherosclerosis Risk in Communities study/
|
Ding, J
|
C. V. Mosby Co
|
2003
|
|
|
|
| 4 |
|
Radical antegrade modular pancreatosplenectomy/
|
Strasberg, S. M
|
C. V. Mosby Co
|
2003
|
|
|
|
| 5 |
|
Radioguided parathyroidectomy in patients with secondary and tertiary hyperparathyroidism/
|
Nichol, P. F
|
C. V. Mosby Co
|
2003
|
|
|
|
| 6 |
|
Radionuclide viability testing: Should it affect treatment strategy in patients with cardiomyopathy and significant coronary artery disease?/
|
Bourque, J. M
|
C. V. Mosby Co
|
2003
|
|
|
|
| 7 |
|
Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease/
|
Kleber, F.-X
|
C. V. Mosby Co
|
2003
|
|
|
|
| 8 |
|
Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial/
|
Goldberg, L. R
|
C. V. Mosby Co
|
2003
|
|
|
|
| 9 |
|
Receive tables of contents by e-mail/
|
|
C. V. Mosby Co
|
2003
|
|
|
|
| 10 |
|
"Receive TOC by e-mail" box/
|
|
C. V. Mosby Co
|
2003
|
|
|
|
| 11 |
|
Recruiting faculty: a science and an art/
|
Rikkers, L. F
|
C. V. Mosby Co
|
2003
|
|
|
|
| 12 |
|
Reduction in obesity and coronary risk factors after high caloric exercise training in overweight coronary patients/
|
Savage, P. D
|
C. V. Mosby Co
|
2003
|
|
|
|
| 13 |
|
Regional angiogenesis with vascular endothelial growth factor (VEGF) in peripheral arterial disease: Design of the RAVE trial/
|
Rajagopalan, S
|
C. V. Mosby Co
|
2003
|
|
|
|
| 14 |
|
Regional variation in the treatment and outcomes of myocardial infarction: investigating New England's advantage/
|
Krumholz, H. M
|
C. V. Mosby Co
|
2003
|
|
|
|
| 15 |
|
Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: The Strong Heart Study/
|
Palmieri, V
|
C. V. Mosby Co
|
2003
|
|
|
|
| 16 |
|
Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: The Losartan Intervention For Endpoint Reduction (LIFE) study/
|
Oikarinen, L
|
C. V. Mosby Co
|
2003
|
|
|
|
| 17 |
|
Relationship of ventricular longitudinal function to contractile reserve in patients with mitral regurgitation/
|
Haluska, B. A
|
C. V. Mosby Co
|
2003
|
|
|
|
| 18 |
|
Relative hyperoxia augments lipopolysaccharide-stimulated cytokine secretion by murine macrophages/
|
Danielson, D. S
|
C. V. Mosby Co
|
2003
|
|
|
|
| 19 |
|
Relativity: Societies, universities, and surgeons/
|
Matthews, J. B
|
C. V. Mosby Co
|
2003
|
|
|
|
| 20 |
|
Reliability of reporting left ventricular systolic function by echocardiography: A systematic review of 3 methods/
|
McGowan, J. H
|
C. V. Mosby Co
|
2003
|
|
|
|